
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $543K | $913.1M | $436K | $370M | $35M | |
Revenue Growth (YoY) | -99.81% | 168054.88% | -99.95% | 84762.39% | -90.54% | |
Cost of Revenues | -- | $101.2M | $110.3M | $130.3M | $110.3M | |
Gross Profit | -- | $811.9M | -$109.8M | $239.8M | -$75.3M | |
Gross Profit Margin | -- | 88.92% | -25186.7% | 64.8% | -215% | |
R&D Expenses | $266.9M | $340.6M | $461.6M | $387.3M | $320.7M | |
Selling, General & Admin | $88.2M | $99.7M | $102.5M | $76.2M | $73M | |
Other Inc / (Exp) | $6.4M | $6M | $22.7M | $71.8M | $103.9M | |
Operating Expenses | $355M | $438.4M | $563.3M | $462.3M | $391.3M | |
Operating Income | -$354.4M | $373.5M | -$673.2M | -$222.5M | -$466.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$348.1M | $379.5M | -$650.5M | -$150.7M | -$362.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $809K | $1.9M | -$325K | $2.9M | $3.6M | |
Net Income to Company | -$348.9M | $377.7M | -$650.2M | -$153.6M | -$366.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$348.9M | $377.7M | -$650.2M | -$153.6M | -$366.3M | |
Basic EPS (Cont. Ops) | -$5.29 | $4.97 | -$8.36 | -$1.94 | -$4.34 | |
Diluted EPS (Cont. Ops) | -$5.29 | $4.70 | -$8.36 | -$1.94 | -$4.34 | |
Weighted Average Basic Share | $65.9M | $75.9M | $77.7M | $79.2M | $84.4M | |
Weighted Average Diluted Share | $65.9M | $80.4M | $77.7M | $79.2M | $84.4M | |
EBITDA | -$345.3M | $391.5M | -$649M | -$202.7M | -$447.3M | |
EBIT | -$354.4M | $373.5M | -$673.2M | -$222.5M | -$466.6M | |
Revenue (Reported) | $543K | $913.1M | $436K | $370M | $35M | |
Operating Income (Reported) | -$354.4M | $373.5M | -$673.2M | -$222.5M | -$466.6M | |
Operating Income (Adjusted) | -$354.4M | $373.5M | -$673.2M | -$222.5M | -$466.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $202K | $178K | $100M | -- | -- | |
Revenue Growth (YoY) | 28.66% | -11.88% | 56079.78% | -- | -- | |
Cost of Revenues | $19.9M | $30.6M | $42.2M | $47M | $57.5M | |
Gross Profit | -$19.7M | -$30.5M | $57.8M | -$47M | -$57.5M | |
Gross Profit Margin | -9773.76% | -17116.85% | 57.81% | -- | -- | |
R&D Expenses | $70.6M | $118.2M | $99.9M | $76.2M | $72.5M | |
Selling, General & Admin | $24.5M | $28M | $22.4M | $18M | $19.3M | |
Other Inc / (Exp) | $2M | $363K | $12.7M | $24.7M | $13.5M | |
Operating Expenses | $94.8M | $145.5M | $122.3M | $93.6M | $90.9M | |
Operating Income | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$112.6M | -$175.6M | -$51.7M | -$115.9M | -$134.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $575K | $3.6M | $1.3M | $724K | $1.1M | |
Net Income to Company | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Basic EPS (Cont. Ops) | -$1.51 | -$2.32 | -$0.67 | -$1.43 | -$1.58 | |
Diluted EPS (Cont. Ops) | -$1.51 | -$2.32 | -$0.67 | -$1.43 | -$1.58 | |
Weighted Average Basic Share | $75M | $77.1M | $78.7M | $81.8M | $85.9M | |
Weighted Average Diluted Share | $75M | $77.1M | $78.7M | $81.8M | $85.9M | |
EBITDA | -$111.8M | -$169.9M | -$59.4M | -$135.8M | -$143.7M | |
EBIT | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Revenue (Reported) | $202K | $178K | $100M | -- | -- | |
Operating Income (Reported) | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Operating Income (Adjusted) | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $588K | $913.1M | $100.3M | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $111.9M | $121.8M | $135M | -- | |
Gross Profit | -- | $801.2M | -$21.5M | $135M | -$85.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $283.4M | $387.2M | $443.3M | $363.6M | $317M | |
Selling, General & Admin | $93.2M | $104.2M | $96.8M | $71.8M | $74.3M | |
Other Inc / (Exp) | $4.1M | $4.4M | $35M | $83.8M | $92.7M | |
Operating Expenses | $376M | $489.1M | $540.1M | $433.6M | $388.6M | |
Operating Income | -$395.4M | $312.1M | -$561.7M | -$298.6M | -$474.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$391.3M | $316.5M | -$526.6M | -$214.8M | -$381.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | $4.9M | -$2.6M | $2.3M | $4M | |
Net Income to Company | -$392.3M | $311.6M | -$524M | -$217.1M | -$385.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$392.3M | $311.6M | -$524M | -$217.1M | -$385.7M | |
Basic EPS (Cont. Ops) | -$5.65 | $4.18 | -$6.72 | -$2.69 | -$4.52 | |
Diluted EPS (Cont. Ops) | -$5.65 | $3.61 | -$6.72 | -$2.69 | -$4.52 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$385.6M | $333.4M | -$538.5M | -$279M | -$455.2M | |
EBIT | -$395.4M | $312.1M | -$561.7M | -$298.6M | -$474.4M | |
Revenue (Reported) | $588K | $913.1M | $100.3M | -- | -- | |
Operating Income (Reported) | -$395.4M | $312.1M | -$561.7M | -$298.6M | -$474.4M | |
Operating Income (Adjusted) | -$395.4M | $312.1M | -$561.7M | -$298.6M | -$474.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $202K | $178K | $100M | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $19.9M | $30.6M | $42.2M | $47M | $57.5M | |
Gross Profit | -$19.7M | -$30.5M | $57.8M | -$47M | -$57.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $70.6M | $118.2M | $99.9M | $76.2M | $72.5M | |
Selling, General & Admin | $24.5M | $28M | $22.4M | $18M | $19.3M | |
Other Inc / (Exp) | $2M | $363K | $12.7M | $24.7M | $13.5M | |
Operating Expenses | $94.8M | $145.5M | $122.3M | $93.6M | $90.9M | |
Operating Income | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$112.6M | -$175.6M | -$51.7M | -$115.9M | -$134.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $575K | $3.6M | $1.3M | $724K | $1.1M | |
Net Income to Company | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Basic EPS (Cont. Ops) | -$1.51 | -$2.32 | -$0.67 | -$1.43 | -$1.58 | |
Diluted EPS (Cont. Ops) | -$1.51 | -$2.32 | -$0.67 | -$1.43 | -$1.58 | |
Weighted Average Basic Share | $75M | $77.1M | $78.7M | $81.8M | $85.9M | |
Weighted Average Diluted Share | $75M | $77.1M | $78.7M | $81.8M | $85.9M | |
EBITDA | -$111.8M | -$169.9M | -$59.4M | -$135.8M | -$143.7M | |
EBIT | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Revenue (Reported) | $202K | $178K | $100M | -- | -- | |
Operating Income (Reported) | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M | |
Operating Income (Adjusted) | -$114.5M | -$176M | -$64.5M | -$140.6M | -$148.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.2B | $923M | $211.9M | $389.5M | $298.3M | |
Short Term Investments | $521.7M | $1.5B | $1.6B | $1.3B | $1.6B | |
Accounts Receivable, Net | $144K | $305K | -- | $200M | $25M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $26.1M | -- | -- | -- | -- | |
Other Current Assets | -- | $38.1M | $37.7M | $14.4M | $8.3M | |
Total Current Assets | $1.7B | $2.4B | $1.9B | $1.9B | $1.9B | |
Property Plant And Equipment | $93M | $312M | $320.6M | $305.9M | $277.6M | |
Long-Term Investments | -- | -- | $53.1M | $2M | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $18.1M | $22.2M | $16.3M | $13.6M | $27.3M | |
Total Assets | $1.8B | $2.8B | $2.2B | $2.2B | $2.2B | |
Accounts Payable | $9.1M | $14.8M | $27.4M | $38.1M | $14.7M | |
Accrued Expenses | $53.8M | $91M | $77.7M | $45.3M | $41.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $11.4M | $12.2M | $15.8M | $15.6M | $17.3M | |
Other Current Liabilities | $7.2M | $171K | $20K | $5.1M | $10.4M | |
Total Current Liabilities | $94.3M | $119.9M | $121.1M | $108.8M | $87.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $163.7M | $352.4M | $367.6M | $346.8M | $310M | |
Common Stock | $2.3M | $2.4M | $2.4M | $2.5M | $2.7M | |
Other Common Equity Adj | -$83K | -$5.1M | -$15.6M | $1.9M | $1.8M | |
Common Equity | $1.7B | $2.4B | $1.9B | $1.9B | $1.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.7B | $2.4B | $1.9B | $1.9B | $1.9B | |
Total Liabilities and Equity | $1.8B | $2.8B | $2.2B | $2.2B | $2.2B | |
Cash and Short Terms | $1.7B | $2.4B | $1.8B | $1.7B | $1.9B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $683.9M | $344.4M | $707.4M | $235.2M | |
Short Term Investments | $680.1M | $1.5B | $1.5B | $1.4B | $1.6B | |
Accounts Receivable, Net | $150K | $143K | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $26M | $39.2M | -- | -- | -- | |
Other Current Assets | -- | -- | $24.8M | $11.5M | $12.3M | |
Total Current Assets | $1.8B | $2.3B | $1.9B | $2.1B | $1.9B | |
Property Plant And Equipment | $102M | $329M | $315.5M | $298.5M | $269.7M | |
Long-Term Investments | -- | -- | $6.3M | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $23.3M | $16.5M | $14.5M | $20.9M | $28.8M | |
Total Assets | $2B | $2.6B | $2.2B | $2.4B | $2.2B | |
Accounts Payable | $13.1M | $27.1M | $45.2M | $16.5M | $13.1M | |
Accrued Expenses | $49.9M | $72.6M | $85.6M | $76.4M | $84.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $12.1M | $11.1M | $15.7M | $16M | $17.5M | |
Other Current Liabilities | $2.9M | $270K | $20K | $4.8M | -- | |
Total Current Liabilities | $83.1M | $113.7M | $146.8M | $119M | $119.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $152.4M | $361.3M | $389.5M | $355.1M | $336.9M | |
Common Stock | $2.3M | $2.4M | $2.5M | $2.7M | $2.7M | |
Other Common Equity Adj | -$461K | -$16.9M | -$9.4M | -$1.6M | $4.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.8B | $2.2B | $1.9B | $2.1B | $1.8B | |
Total Liabilities and Equity | $2B | $2.6B | $2.2B | $2.4B | $2.2B | |
Cash and Short Terms | $1.8B | $2.2B | $1.9B | $2.1B | $1.9B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$348.9M | $377.7M | -$650.2M | -$153.6M | -$366.3M | |
Depreciation & Amoritzation | $9.2M | $18M | $24.2M | $19.8M | $19.3M | |
Stock-Based Compensation | $66M | $102.4M | $97.9M | $81M | $86.6M | |
Change in Accounts Receivable | -$45K | -$161K | $305K | -$200M | $175M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$238.4M | $539M | -$495.7M | -$260.4M | -$142.8M | |
Capital Expenditures | $18.4M | $81.7M | $37.2M | $12M | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$541.2M | -$1B | -$258.7M | $374.6M | -$280.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $1B | $250.9M | $38.6M | $62.7M | $332M | |
Beginning Cash (CF) | $948.8M | $1.2B | $939.9M | $224.1M | $401.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $236.6M | -$245.5M | -$715.8M | $176.9M | -$91.3M | |
Ending Cash (CF) | $1.2B | $939.9M | $224.1M | $401.1M | $309.8M | |
Levered Free Cash Flow | -$256.7M | $457.3M | -$532.9M | -$272.3M | -$144.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Depreciation & Amoritzation | $2.7M | $6M | $5.1M | $4.8M | $4.7M | |
Stock-Based Compensation | $22.1M | $25.7M | $20.9M | $19.4M | $20.2M | |
Change in Accounts Receivable | -$6K | $162K | -- | $200M | $25M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$100.7M | -$135.2M | $8.8M | $109.8M | -$53.9M | |
Capital Expenditures | $7M | $15.4M | $3.1M | $721K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$167.9M | -$114.5M | $117.8M | -$97.8M | -$19.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $226M | $10.6M | $5.4M | $305.9M | $10.6M | |
Beginning Cash (CF) | $1.2B | $939.9M | $224.1M | $401.1M | $309.8M | |
Foreign Exchange Rate Adjustment | $5K | -$27K | $32K | -$11K | $41K | |
Additions / Reductions | -$42.6M | -$239.1M | $132M | $317.9M | -$63.1M | |
Ending Cash (CF) | $1.1B | $700.8M | $356.1M | $718.9M | $246.7M | |
Levered Free Cash Flow | -$107.7M | -$150.6M | $5.7M | $109M | -$54.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$392.3M | $311.6M | -$524M | -$217.1M | -$385.7M | |
Depreciation & Amoritzation | $9.8M | $21.3M | $23.2M | $19.6M | $19.2M | |
Stock-Based Compensation | $74M | $106M | $93.1M | $79.6M | $87.4M | |
Change in Accounts Receivable | $25M | $7K | $143K | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$286.9M | $504.4M | -$351.7M | -$159.4M | -$306.5M | |
Capital Expenditures | $22.4M | $90M | $24.9M | $9.6M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$706.1M | -$982M | -$26.3M | $159M | -$202.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $1.2B | $35.6M | $33.3M | $363.2M | $36.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $248.1M | -$442M | -$344.7M | $362.8M | -$472.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$309.2M | $414.4M | -$376.6M | -$169.1M | -$307.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$113.2M | -$179.2M | -$53.1M | -$116.6M | -$136M | |
Depreciation & Amoritzation | $2.7M | $6M | $5.1M | $4.8M | $4.7M | |
Stock-Based Compensation | $22.1M | $25.7M | $20.9M | $19.4M | $20.2M | |
Change in Accounts Receivable | -$6K | $162K | -- | $200M | $25M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$100.7M | -$135.2M | $8.8M | $109.8M | -$53.9M | |
Capital Expenditures | $7M | $15.4M | $3.1M | $721K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$167.9M | -$114.5M | $117.8M | -$97.8M | -$19.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $226M | $10.6M | $5.4M | $305.9M | $10.6M | |
Beginning Cash (CF) | $1.2B | $939.9M | $224.1M | $401.1M | $309.8M | |
Foreign Exchange Rate Adjustment | $5K | -$27K | $32K | -$11K | $41K | |
Additions / Reductions | -$42.6M | -$239.1M | $132M | $317.9M | -$63.1M | |
Ending Cash (CF) | $1.1B | $700.8M | $356.1M | $718.9M | $246.7M | |
Levered Free Cash Flow | -$107.7M | -$150.6M | $5.7M | $109M | -$54.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.